BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18359023)

  • 1. Luteal phase estradiol level: a potential predictive marker for successful pregnancy in in vitro fertilization/intracytoplasmic sperm injection.
    Ganesh A; Goswami S; Chattopadhyay R; Chakraborty C; Chaudhury K; Chakravarty BN
    Fertil Steril; 2009 Apr; 91(4):1018-22. PubMed ID: 18359023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and midluteal phase blood estradiol levels after ovum pickup and pregnancy rates after ICSI cycles.
    Levi R; Ozyurek SE; Goker EN; Tavmergen EH
    J Reprod Med; 2004 Feb; 49(2):108-14. PubMed ID: 15018439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of mid-luteal estradiol level on the outcome of ICSI-ET cycles.
    Aktan E; Bozkurt K; Ozer D; Yucebilgin S; Karadadas N; Bilgin O
    Arch Gynecol Obstet; 2004 Jan; 269(2):134-8. PubMed ID: 12928936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles.
    Lukaszuk K; Liss J; Lukaszuk M; Maj B
    Fertil Steril; 2005 May; 83(5):1372-6. PubMed ID: 15866571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial.
    Ghanem ME; Sadek EE; Elboghdady LA; Helal AS; Gamal A; Eldiasty A; Bakre NI; Houssen M
    Fertil Steril; 2009 Aug; 92(2):486-93. PubMed ID: 19464001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer.
    Drakakis P; Loutradis D; Vomvolaki E; Stefanidis K; Kiapekou E; Anagnostou E; Anastasiadou K; Milingos S; Antsaklis A
    Gynecol Endocrinol; 2007 Nov; 23(11):645-52. PubMed ID: 17999276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
    Kleinstein J;
    Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of soluble vascular cell adhesion molecule-1, tumor necrosis factor-alpha, and interleukin-6 in in vitro fertilization cycles.
    Souter I; Huang A; Martinez-Maza O; Breen EC; Decherney AH; Chaudhuri G; Nathan L
    Fertil Steril; 2009 May; 91(5 Suppl):2012-9. PubMed ID: 18778820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis for clinical pregnancy and delivery after total fertilization failure during conventional in vitro fertilization or intracytoplasmic sperm injection.
    Kinzer DR; Barrett CB; Powers RD
    Fertil Steril; 2008 Aug; 90(2):284-8. PubMed ID: 17714711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone levels on oocyte retrieval day can predict the quantity of viable embryos but not pregnancy outcome of intracytoplasmic sperm injection.
    Niu Z; Feng Y; Zhang A; Sun Y; Zhang H
    Gynecol Endocrinol; 2008 Aug; 24(8):452-8. PubMed ID: 18850383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
    Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
    Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.
    Florêncio RS; Meira MSB; Cunha MVD; Camarço MNCR; Castro EC; Finotti MCCF; Oliveira VA
    JBRA Assist Reprod; 2018 Mar; 22(1):8-14. PubMed ID: 29338136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C; Donnez J; Loumaye E
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicle-stimulating hormone and estradiol levels independently predict the success of assisted reproductive technology treatment.
    Frazier LM; Grainger DA; Schieve LA; Toner JP
    Fertil Steril; 2004 Oct; 82(4):834-40. PubMed ID: 15482756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.